SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is seeing a dramatic surge after reporting strong earnings that surpassed expectations and offering upbeat guidance for the first quarter, alongside bullish long-term EBITDA per share projections for 2027. This momentum is driven by robust demand for its 800G and 1.6T transceiver products from hyperscale data centers, though some in the community are voicing concerns regarding a recent $250 million common stock offering.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is igniting investor excitement following its CEO's high-profile media appearances, which highlighted powerful patient testimonials and scientific advancements in IL-15 based cancer and longevity treatments, fueling community discussions about Anktiva's universal impact and intensifying pressure on shorts.

Green Satoshi Token

Green Satoshi Token (GSTSOL) is sparking intense debate as many anticipate a significant upward move driven by increasing volume and technical signals, while a skeptical faction voices concerns over its history of dilution and prior performance amidst the broader altcoin market's renewed optimism.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMC Robotics (AMCI) is attracting significant attention as new strategic collaborations, global manufacturing expansion into Vietnam, and the imminent commercial launch of its NovaArm robot highlight its potential in the burgeoning AI and robotics sector. Despite community discussions around low trading volume and warrant exercises impacting the stock, investors are keenly anticipating major contracts to ignite a substantial run, especially with a tightly held float.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT &amp; Merchandise Marketplace.

Floki Token

Floki is trending as its dedicated 'Vikings' community rallies behind recent ecosystem developments, including new trading bot features and airdrops. This meme coin is also gaining traction through the launch of ETPs in Europe, sparking both bullish anticipation and debate over its price volatility among market participants.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is in focus after securing new equity financing, with community sentiment divided between those optimistic about its expanding vehicle lineup and record sales growth, and skeptics highlighting persistent profitability concerns amid broader EV market challenges.

VanEck ETF Trust - VanEck Video Gaming and eSports ETF

VanEck Video Gaming and eSports ETF

VanEck Video Gaming and eSports ETF ($ESPO) is trending as it consistently appears in top-ranking lists for long-term communications sector holdings, fueled by sustained community interest in the enduring growth potential of the video gaming and esports industry.

Ultra Clean Holdings, Inc. engages in the development and supplying of critical subsystems, components and parts, and ultra-high purity cleaning and analytical services for the semiconductor industry. It operates through the Products and Services segments. The Products segment is involved in the design and manufacture of production tools, components, parts, and modules, and subsystems for the semiconductor and display capital equipment industry. The Services segment provides purity parts cleaning, process tool part recoating, surface encapsulation, and high sensitivity micro contamination analysis for the semiconductor device makers and wafer fabrication equipment. The company was founded in November 2002 and is headquartered in Hayward, CA.

Ultra Clean Hldgs Inc

Ultra Clean Holdings is trending due to mixed reactions surrounding a convertible debt offering that prompted short-term selling, despite the company reporting strong earnings and highlighting a positive long-term outlook for structural expansion in the semiconductor equipment and AI-driven advanced packaging markets.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is at the center of market conversation following its recent earnings, which signaled much higher capital expenditure for future AI infrastructure and fueled investor concern over its debt model and near-term profitability. While many highlight the immense demand and substantial backlog as a long-term opportunity, others are questioning the aggressive spending and labeling the steep sell-off as a deserved reaction to perceived financial strain.

Hawaiian Electric Industries, Inc. is a holding company, which engages in electric utility and non-regulated renewable and sustainable infrastructure businesses. The company was founded by C. Dudley Pratt Jr. in 1981 and is headquartered in Honolulu, HI.

Hawaiian Electric Industries, Inc.

Hawaiian Electric is actively debated as recent earnings and ongoing wildfire liability settlements drive conversation, with investors optimistic about a potential legislative liability cap and institutional accumulation. However, others caution about continued dilution risks from funding future payments, creating a polarized outlook for the utility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of +13.71% and +103.43%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

<ul class="summary-bullets"><li>Ocugen is advancing OCU400 to address all gene mutations associated with retinitis pigmentosa (RP) with a single, one-time injection.</li><li>The company is looking to make a rolling Biologics License Application for OCU400.&nbsp;</li><li>In a previous study, all subjects treated with OCU400 showed improvement or preservation in visual function compared to untreated eyes after two years.</li></ul>Shares of Ocugen Inc. (OCGN) rose nearly 5% on Wednesday after the company said that it plans to start seeking the approval of the U.S. Food and Drug Administration (FDA) for its experimental therapy, OCU400, starting this year.Ocugen is advancing OCU400 to address all gene mutations associated with retinitis pigmentosa (RP) with a single, one-time injection.“We plan to begin the rolling submission for the OCU400 Biologics License Application this year and potentially provide a treatment option for the 98% of RP patients for whom no therapy exists,” the company said in a post on <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.linkedin.com/feed/update/urn:li:activity:7432479854509400064/">LinkedIn</a>.<h2 class="st-heading-2">About Retinitis pigmentosa</h2>Retinitis pigmentosa (RP) is a group of rare, inherited genetic disorders causing slow, progressive retinal degeneration and vision loss, typically starting with night blindness and peripheral vision loss (tunnel vision) in childhood or young adulthood. Ocugen estimates the condition affects about 300,000 people in the U.S. and Europe combined.In a previous study including 18 subjects, OCU400 demonstrated sustained favorable safety and tolerability. All the treated subjects showed improvement or preservation in visual function compared to untreated eyes after two years, the company said.In November, the company said that it is looking to initiate an application to the FDA for approval of the therapy in the first half of 2026. Ocugen is looking to make a rolling Biologics License Application, an FDA-approved process that allows pharmaceutical companies to submit completed sections or modules of their application for review as they are finished, rather than waiting to submit the entire document at once.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around OCGN stock stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<a href="https://stocktwits.com/symbol/OCGN">OCGN stock</a> has more than tripled over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/mannkind-stock-plummets-after-partner-united-therapeutics-unveils-new-category-killer-product/cZRyOedRIGN">MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Why Did OCGN Stock Rise Today?

Ocugen said that it intends to start seeking the approval of the FDA for its experimental therapy OCU400 starting this year. 

Equity

Ocugen (OCGN) Expected to Announce Earnings on Wednesday

Ocugen (NASDAQ:OCGN) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 4. (View Earnings Report at...

Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates

Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -54.76% and +0.24%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ocugen (NASDAQ:OCGN) Trading 6.6% Higher - Here's Why

Ocugen (NASDAQ:OCGN) Stock Price Up 6.6% - Time to Buy...

Ocugen (NASDAQ:OCGN) Trading 2.1% Higher - Time to Buy?

Ocugen (NASDAQ:OCGN) Trading 2.1% Higher - Here's Why...

Moderna (MRNA) Reports Q4 Loss, Beats Revenue Estimates

Moderna (MRNA) delivered earnings and revenue surprises of +18.75% and +2.81%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ocugen (NASDAQ:OCGN) Trading 12.4% Higher - Time to Buy?

Ocugen (NASDAQ:OCGN) Trading Up 12.4% - What's Next...

Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering

Ocugen shares sank sharply Wednesday after the biotech company announces a $22.5 million underwritten offering of common stock.read more...

Ocugen's (OCGN) "Buy" Rating Reiterated at Chardan Capital

Chardan Capital reissued a "buy" rating and set a $7.00 price objective on shares of Ocugen in a report on Tuesday...

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Ocugen Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

OCGN
Ocugen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OCGN News

OCGNOcugen Inc